Acumen Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Acumen Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Acumen Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acumen Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.3k | 3.0k | 1.75 |
| 2025-03-31 | $1.5M | 832k | 1.75 |
| 2024-12-31 | $1.6M | 938k | 1.72 |
| 2024-09-30 | $156k | 63k | 2.48 |
| 2024-06-30 | $60k | 18k | 3.36 |
| 2024-03-31 | $291k | 72k | 4.05 |
| 2023-12-31 | $130k | 34k | 3.84 |
| 2023-09-30 | $46k | 11k | 4.17 |
| 2023-06-30 | $6.1k | 1.3k | 4.81 |
| 2023-03-31 | $5.0k | 1.2k | 4.04 |
| 2022-12-31 | $6.0k | 1.1k | 5.31 |
| 2022-06-30 | $8.0k | 1.6k | 4.93 |
| 2022-03-31 | $72k | 18k | 3.97 |
| 2021-12-31 | $49k | 7.2k | 6.73 |